ResApp Health Ltd (ASX:RAP) has been granted a trading halt by the ASX, pending details of a capital raising.
The company is developing smartphone medical applications for the diagnosis and management of respiratory disease.
The halt will remain in place until the opening of trade on Wednesday 20th April 2016, or earlier if an announcement is made to the market.
Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.